ABT
Abbott Laboratories
$107.15
▲ +1.37%
+$1.45
NYSE · Healthcare · Medical Devices
· price updated 9h ago
Abbott Laboratories
ABT · NYSE · Healthcare · Medical Devices · price updated 9h ago
$107.15
▲ +1.37% · +$1.45 today
AI research · $107.15
ABT, researched
Beat-and-raise reignites Abbott's growth story
refreshed Jul 17
price position
Where ABT sits now
52-week range
Low$81.97
High$137.49
Today $107.15
RSI (14)
69.4Neutral
03070100
fundamentals
Business quality and valuation
Operating record
What the business has actually produced
Revenue
Capital structure
Cash versus debt
Cash & investments$5.6B
Total debt$32.6B
Net cash after debt$-27.0B
Valuation
What the market charges
Forward P/E
Price against expected earnings
Favorable · 13% below Sector avg · favorable
18.23x
Price / sales
Value assigned to each sales dollar
Reasonable · Between 3x and 8x sales
3.93x
Price / FCF
Price against free cash generation
Reasonable · Between 20x and 35x free cash flow
23.38x
EV / EBITDA
Operating value including debt
Reasonable · Between 12x and 22x EBITDA
19.46x
Quality
How efficiently it compounds
ROIC
Return earned on invested capital
Weak · Below 8% return on capital
7.5%
ROE
Profit generated from shareholder equity
Middle ground · Roughly in line with sector
10.6%
Debt / equity
Balance-sheet leverage
Favorable · Ahead of most sector peers
0.63x
Current ratio
Short-term assets against liabilities
Reasonable · Assets still cover near-term liabilities
1.38x
Geographic mix
Jun 30, 2026International61.0% · $28.4B
United States39.0% · $18.2B
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
peer comparison
How ABT compares
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $182.90B | 34.2 | +8.1% | 56 |
 | $10.69B | 18.4 | +23.5% | 78 |
 | $4.88B | 20.3 | +10.3% | 77 |
 | $31.49B | 32.9 | +15.5% | 77 |
 | $1.08T | 41.4 | +47.4% | 76 |
US stock research
About Abbott Laboratories (ABT) stock
Abbott Laboratories tracked in the US core universe. ABT was +1.4% in the latest available session at $107.15. Its reported market value was $182.90B with a trailing P/E of 34.2. Latest reported revenue was $46.59B, changing +8.1% year over year, with $5.42B in net income.
Market snapshot updated Aug 3, 2026, 7:59 PM UTC.
- Latest available price
- $107.15
- Day change
- +1.4%
- Market cap
- $182.90B
- P/E (TTM)
- 34.2
- Revenue growth
- +8.1%
- Industry
- Medical Devices